Basic Information
| LncRNA/CircRNA Name | ASB16-AS1? |
| Synonyms | NA |
| Region | GRCh38_17:44175973-44186717 |
| Ensemble | ENSG00000267080 |
| Refseq | NR_049729 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qRT-PCR, Western blot |
| Sample | NSCLC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | LncRNA ASB16-AS1 is up-regulated in NSCLC tissues and cells, which promotes proliferation and inhibits apoptosis of NSCLC cells through the Wnt/?-catenin signaling pathway. |
| Pubmed ID | 32141556 |
| Year | 2020 |
| Title | LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/? catenin signaling pathway |
External Links
| Links for ASB16-AS1? | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |